Trial NCT04784559

View at ClinicalTrials.gov 
Org. Study IDs: APL-D-003-20
Secondary IDs: 2020-005951-19

Last trial update was posted on 2023-03-09

MeSH Interventions

Dexamethasone Favipiravir Remdesivir

MeSH Conditions

COVID-19 Communicable Diseases Infections

Other Conditions

COVID-19 Infection

Stopping Reasons

Sponsor has decided to end the study prematurely based on significant difficulties in the recruitment of patients, despite the implementation of corrective measures that still failed to increase the accrual rate required for a feasible completion.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID